Allergan Aesthetics is launching AA Signature, a collection of patient-centric, multimodal consultation approaches that leverage Allergan Medical Institute (AMI) resources and Allergan Aesthetics products.
The program will debut with AA Signature: SKIN360, a patient-centric consultation approach featuring SKINVIVE by JUVÉDERM, SkinMedica HA5 Hydra Collagen Hydrator with Vegan Collagen, and BOTOX Cosmetic (onabotulinumtoxinA).
Subsequent aesthetic consultation protocols will debut through 2027 and will address key patient concerns, including lift, structure, skin firmness, and facial definition. Providers interested in additional resources and training materials may speak with their Allergan Aesthetics business development representative for more information.
“Since implementing the AA Signature: SKIN360 assessment in my practice, I’ve been able to take a more holistic approach to my patient consultations, extending them to assess concerns across the face, neck, and décolleté,” says Emily Schultz, RN, CANS, an Aesthetic Nurse Specialist based in Ontario, Canada, in a news release. “The program provides practical clinical tools that enhance consultation quality, support individualized treatment planning, and help patients better understand their aesthetic options.”
“At Allergan Aesthetics, we believe leadership means not only advancing science and innovation but also equipping providers with the tools they need to succeed in a rapidly evolving market,” adds Nicole Mowad-Nassar, senior vice president, AbbVie, and president, Global Allergan Aesthetics. “AA Signature represents a new approach to treatment planning, helping HCPs deliver personalized, multimodal assessments backed by Allergan Aesthetics’ robust product portfolio. By enabling more meaningful patient consultations and individualized treatment journeys, we are helping shape the future of aesthetic medicine.”